Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study to Inform the Design of a Randomised Controlled Trial to Identify the Most Clinically and Cost Effective Length of Anticoagulation With Low Molecular Weight Heparin In the Treatment of Cancer Associated Thrombosis

NCT01817257 is registered in ClinicalTrials.gov with Cardiff University as lead sponsor.

NCT NCT01817257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01817257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study to Inform the Design of a Randomised Controlled Trial to Identify the Most Clinically and Cost Effective Length of Anticoagulation With Low Molecular Weight Heparin In the Treatment of Cancer Associated Thrombosis
Lead sponsor
Cardiff University
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2013
Completion date
February 28, 2015
Enrollment
2 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, deep vein thrombosis, pulmonary embolus, thrombosis, venous thromboembolism